Andrew Craig Miller is President of R&D of Karuna Therapeutics, Inc.. Currently has a direct ownership of 0 shares of KRTX, which is worth approximately $0. The most recent transaction as insider was on Mar 18, 2024, when has been sold 23,389 shares (Common Stock) at a price of $330.0 per share, resulting in proceeds of $7,718,370. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
100.0% 12M change
Total Value Held $0

Andrew Craig Miller Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Sale (or disposition) back to the issuer
$7,718,370 $330.0 p/Share
23,389 Reduced 100.0%
0 Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$320,628 $317.14 p/Share
1,011 Reduced 4.14%
23,389 Common Stock
Apr 20 2023
SELL
Open market or private sale
$3,001,950 $200.13 p/Share
15,000 Reduced 38.07%
24,400 Common Stock
Apr 20 2023
BUY
Exercise of conversion of derivative security
$78,200 $9.2 p/Share
8,500 Added 17.75%
39,400 Common Stock
Apr 18 2023
SELL
Open market or private sale
$6,004,800 $200.16 p/Share
30,000 Reduced 49.26%
30,900 Common Stock
Apr 18 2023
BUY
Exercise of conversion of derivative security
$276,000 $9.2 p/Share
30,000 Added 33.0%
60,900 Common Stock
Feb 09 2023
BUY
Grant, award, or other acquisition
-
12,550 Added 28.88%
30,900 Common Stock
Dec 21 2022
BUY
Exercise of conversion of derivative security
$20,732 $2.92 p/Share
7,100 Added 27.9%
18,350 Common Stock
Dec 02 2022
BUY
Exercise of conversion of derivative security
$3,824 $5.1 p/Share
750 Added 2.78%
26,250 Common Stock
Dec 01 2022
SELL
Open market or private sale
$3,424,500 $228.3 p/Share
15,000 Reduced 57.14%
11,250 Common Stock
Nov 11 2022
BUY
Exercise of conversion of derivative security
$10,200 $5.1 p/Share
2,000 Added 4.71%
40,500 Common Stock
Nov 10 2022
SELL
Open market or private sale
$3,389,700 $225.98 p/Share
15,000 Reduced 37.04%
25,500 Common Stock
Nov 03 2022
BUY
Exercise of conversion of derivative security
$5,840 $2.92 p/Share
2,000 Added 3.6%
53,500 Common Stock
Nov 01 2022
SELL
Open market or private sale
$3,376,200 $225.08 p/Share
15,000 Reduced 28.04%
38,500 Common Stock
Nov 02 2021
BUY
Exercise of conversion of derivative security
$77,380 $2.92 p/Share
26,500 Added 32.79%
54,327 Common Stock
Nov 01 2021
SELL
Open market or private sale
$399,427 $141.29 p/Share
2,827 Reduced 5.2%
51,500 Common Stock
Oct 04 2021
SELL
Open market or private sale
$379,140 $125.17 p/Share
3,029 Reduced 9.82%
27,827 Common Stock
Oct 01 2021
SELL
Open market or private sale
$1,644,540 $122.08 p/Share
13,471 Reduced 30.39%
30,856 Common Stock
Sep 02 2021
SELL
Open market or private sale
$335,488 $125.51 p/Share
2,673 Reduced 5.69%
44,327 Common Stock
Sep 01 2021
SELL
Open market or private sale
$652,685 $118.67 p/Share
5,500 Reduced 10.48%
47,000 Common Stock
Aug 16 2021
SELL
Open market or private sale
$574,035 $104.37 p/Share
5,500 Reduced 9.48%
52,500 Common Stock
Aug 16 2021
BUY
Exercise of conversion of derivative security
$36,500 $2.92 p/Share
12,500 Added 17.73%
58,000 Common Stock
Jun 14 2021
SELL
Open market or private sale
$1,095,421 $131.44 p/Share
8,334 Reduced 15.48%
45,500 Common Stock
Jun 14 2021
BUY
Exercise of conversion of derivative security
$76,673 $9.2 p/Share
8,334 Added 13.41%
53,834 Common Stock
Jun 11 2021
SELL
Open market or private sale
$1,077,707 $129.33 p/Share
8,333 Reduced 15.48%
45,500 Common Stock
ACM

Andrew Craig Miller

President of R&D
Boston, MA

Track Institutional and Insider Activities on KRTX

Follow Karuna Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRTX shares.

Notify only if

Insider Trading

Get notified when an Karuna Therapeutics, Inc. insider buys or sells KRTX shares.

Notify only if

News

Receive news related to Karuna Therapeutics, Inc.

Track Activities on KRTX